Log in or Sign up for Free to view tailored content for your specialty!
Rheumatoid Arthritis News
Physical therapy app, provider phone calls improve rheumatoid arthritis fatigue, self-care
SAN DIEGO — A remote, technology-based physical therapy intervention that included phone calls with a health care provider improved self-management and physical activity in patients with rheumatoid arthritis, according to a speaker.
Medicare fails to ‘keep up with’ Medicaid, private market on infliximab biosimilar uptake
SAN DIEGO — Compared with Medicaid and private insurance, Medicare has lagged significantly in adopting infliximab biosimilars despite the multiple options now available, according to data presented at ACR Convergence 2023.
Log in or Sign up for Free to view tailored content for your specialty!
Hydroxychloroquine use predicts lower risk for fatty liver disease in rheumatoid arthritis
SAN DIEGO — Patients with rheumatoid arthritis who receive hydroxychloroquine demonstrate a lower risk for nonalcoholic fatty liver disease, according to data presented at ACR Convergence 2023.
Real-world monitoring of rheumatoid arthritis-associated ILD ‘suboptimal’
SAN DIEGO — Monitoring of rheumatoid arthritis-associated interstitial lung disease remains highly variable and “suboptimal” in the real world, according to a speaker at ACR Convergence 2023.
Menopausal hormone therapy may increase risk for late-onset rheumatoid arthritis
Oral contraceptives may protect against rheumatoid arthritis, while menopausal hormone therapy could increase risk for late-onset RA, according to data published in Rheumatology.
First patients dosed in clinical trial of small molecule for MS, autoimmune conditions
A Boston-based biopharma company announced the first participants have been dosed in its phase 1 study to assess safety, tolerability and pharmacokinetics of a novel oral, small molecule therapeutic in healthy adults.
Rheumatology referrals often lack key details of patients’ inflammatory arthritis
Key details expressing arthralgia duration, morning stiffness or joint examination findings are often missing from rheumatology referral letters for inflammatory arthritis, according to data published in Rheumatology Advances in Practice.
FDA approves Stelara biosimilar for treatment of psoriasis, multiple inflammatory diseases
The FDA has approved Wezlana as a Stelara biosimilar for the treatment of plaque psoriasis, psoriatic arthritis and other inflammatory diseases, according to an FDA press release.
Little evidence suggests clear superiority of any drug class in rheumatoid arthritis
Little evidence suggests that any specific biologic or targeted synthetic disease-modifying antirheumatic drug is superior to another for rheumatoid arthritis, highlighting the importance of individualized treatment, according to data.
Autoimmunity, Part 3: The Lupus Gradient
In this episode, we dig through the data of lupus in Africa and speak with experts on the Lupus Gradient, the impact of malaria and what we can learn from it all.
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read